XENE Q3 2018 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$6M

Operating Income

-$14M

Net Income

-$14M

EPS (Diluted)

$-0.71

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$687,000

Balance Sheet

Total Assets

$130M

Total Liabilities

$19M

Stockholders' Equity

$111M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$264,000	-100.0%
Gross Profit	-$6M	-$7M	+13.0%
Operating Income	-$14M	-$9M	-64.0%
Net Income	-$14M	-$8M	-85.8%